-
XBB1.5 is more likely to invade the digestive system? Expert: The online hoarding of drugs is not completely scientific
Time of Update: 2023-02-03
Chen Yonghe said that if the diarrhea is too serious, there has been general weakness, collapse and other symptoms, then there may have been electrolyte imbalances, simply taking montmorillonite powder, the effect is not ideal, must seek medical attention in time.
-
Eradication of Helicobacter pylori, drug quadruple therapy is used like this!
Time of Update: 2022-12-04
What is the medication regimen?Dose, usage, and evaluation of antimicrobial combination doses in the Helicobacter pylori eradication quadruple regimen:Note: A standard dose proton pump inhibitor + standard dose bismuth (2 times/d, oral half an hour before meals) + 2 antibacterial drugs (oral after meals).
-
The eighth batch of collective procurement is like an arrow, which drugs are expected to be "collected"?
Time of Update: 2022-10-25
The industry believes that the reply letter of the National Medical Insurance Bureau means that the promotion of centralized procurement of biological drugs may have entered the agenda, and the market pattern of tens of billions of biosimilars will usher in changes in the future.
-
in the international top journal JAMA, H drug Hans-like combination chemotherapy first-line ® treatment of extensive small cell lung cancer positive results were released
Time of Update: 2022-10-13
On September 27, 2022, the international multicenter research led by Professor Cheng Ying, ASTRUM-005 research, one of the world's top four medical journals, Journal of the American Medical Associatio
-
Is the more hypoglycemic drugs people with type 2 diabetes use, the more likely they are to develop "hypoglycemia"?
Time of Update: 2022-10-12
Interestingly, however, the incidence of hypoglycemia decreased significantly from 2010 to 2015 in patients with diabetes, while the proportion of patients using three or more drugs increased, suggesting that the risk of severe hypoglycemia requires consideration of the type of drug rather than the number of drugs, especially in elderly women, taking sulfonylureas requires attention and consideration of the risk of hypoglycemia.
-
BIOSET has entered into a collaboration with Bonn Biotech on the development of cell therapy drugs based on TCR-like antibodies
Time of Update: 2022-09-21
On September 8, 2022, BIOSAITU (Beijing) Pharmaceutical Technology Co. , Ltd. (hereinafter referred to as "BIOSAITU", stock code: 02315. HK) announced that it has entered into a cooperation agreement
-
Map-like atrophy treatment drugs!
Time of Update: 2022-01-05
In May 2021, Empaveli (pegcetacoplan) was approved by the US FDA for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH) .
-
Talking about the drug-like and pharmaceutical properties of innovative drugs
Time of Update: 2021-12-03
Provide new targets and theories for new drug discovery as the upstream basic research stage; use new targets and theories to combine Existing technologies form patents and candidate compounds are the new drug discovery stage; pre-clinical comprehensive evaluation, clinical evaluation, and industrialization process research for candidate drugs are the new drug development stage; registration on the basis of the foregoing is the listing stage .
-
Cell sub-news: new drug-like molecules start from epigenetics to treat cancer
Time of Update: 2021-11-14
Researchers at the University of Southern California and the University of North Carolina at Chapel Hill have recently developed a new drug-like molecule that can counteract the effects of mutations in epigenetic regulatory factors .
-
Cinda Bio-PD-1 and Ipilimumab-like drugs are approved for clinical use in nasopharyngeal carcinoma
Time of Update: 2021-08-02
Currently, according to the Insight database, Cinda has carried out 6 clinical trials of IBI310 combined with Sintilimab in China for hepatocellular carcinoma, cervical cancer, postoperative adjuvant melanoma, and dMMR/MSI-H advanced colorectal cancer .
-
The application for the listing of baiva bead monobial-like drugs was accepted by the FDA
Time of Update: 2021-02-01
Source: Pharmaceutical Mission, January 28, Baotai Bio issued a press release saying that the FDA has accepted the BAT1706 (Beval pearl monobial-like drug) injection biological products market application (BLA), the adaptation of the application includes metastatic colorectal cancer, non-squamous non-small cell lung cancer, relapse glioblastoma, metastatic renal cell carcinoma and persistent, relapsed or metastatic cervical cancer.
-
Like for extraordinary speed! And Yellow Medicine heavy tumor new drug Sutaida ® wholesale goods only half a month
Time of Update: 2021-01-23
(Sovantini capsule) was approved based on the results of a Chinese Phase III clinical trial SANET-ep in the treatment of patients with advanced non-pancreatic neuroendocrine tumors (clinicaltrials.gov registration number NCT02588170).
-
Biotech submits clinical applications for Skuchiu monobial-like drugs
Time of Update: 2021-01-16
Skuchiyu monoantigen is a biologic agent targeting IL-17A, and the original product, secukinumab (English trade name: Cosentyx), has been approved in China for moderate to severe plaque psoriasis (PsO) and strong straight spina boutitis (AS).
-
Adamo monobial-like drug Handa is ® in China
Time of Update: 2021-01-11
On December 26, 2020, Wanbang Pharma, a subsidiary of Shanghai Fosun Pharma (Group) Co., Ltd., officially announced that the Adamo single anti-injection (commodity name: Handayuan®) developed and pro
-
Sword refers to Roche Merro! Amgen Lytoxi monobial-like drug Riamni is approved by the FDA!
Time of Update: 2020-12-26
December 18, 2020 // -- Amgen recently announced that the U.S. Food and Drug Administration (FDA) has approved Ribni (rituximab-arrx, rituximab-rituximab), a Roche ace biologic agent Rituxan (Chinese Product Name: Meroma, generic name: rituximab, rituximab, rituximab biosynthetic drug for the treatment of non-Hodgkin's lymphoma (NHL), chronic lymphocytic leukemia (CLL), granuloma with polyvascularitis (GPA), microscopic multi-hemanitis (MPA) adult patients.